Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7357 p45
9 July 2005

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Drug administration
· National boards
· Controlled drugs
· The Society
· Supermarket pharmacy (2)
· Birdsgrove House (2)
· New pharmacy contract (2)
· Prescribing
· Education


Letters to the Editor

Controlled drugs

“Z” drug correction

From Mrs D. K. Roberts, FRPharmS

In his letter (PJ, 2 July, p18) Brian Curwain incorrectly states that zopiclone “and the other ‘z’ drugs” are not controlled under the Misuse of Drugs legislation. In fact one of the “z” drugs, namely zolpidem was added to schedule 4, part 1, para 1 of the Misuse of Drugs Regulations in 2002. Zolpidem is thus subject to the same level of control as most benzodiazepines. Zolpidem was added to Schedule IV of the United Nations single convention on psychotropic substances in March 2001. As a signatory to this convention, the UK was obliged to amend its legislation, even though at that time UK reports of misuse were low.

Kay Roberts
Glasgow

Send your letter to The Editor

Previous Topic (National boards)
Next Topic (The Society)

Back to Top


©The Pharmaceutical Journal